Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihypertensives and Antilipemics in American Indians With NIDDM
NCT00004266Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 1993
- Primary completion
- Jul 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lisinopril, nifedipine and simvastatin in diabetic nephropathy (DN) and cardiovascular disease (CVD) (4 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoints: Prevention of nephropathy at 3 years and Prevention of vascular disease at 3 years. Started Aug 1993; status: completed.
02
Drugs
lisinoprilnifedipinesimvastatin
03
Conditions
diabetic nephropathy (DN)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00004266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004266.